The estimated Net Worth of Jerome Labat is at least $3.88 Million dollars as of 20 December 2021. Mr Labat owns over 24,521 units of Cerner stock worth over $3,030,458 and over the last 4 years he sold CERN stock worth over $0. In addition, he makes $852,185 as Exec. VP & CTO at Cerner.
Mr has made over 2 trades of the Cerner stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 24,521 units of CERN stock worth $2,328,514 on 20 December 2021.
The largest trade he's ever made was exercising 24,521 units of Cerner stock on 20 December 2021 worth over $2,328,514. On average, Mr trades about 4,500 units every 25 days since 2020. As of 20 December 2021 he still owns at least 31,913 units of Cerner stock.
You can see the complete history of Mr Labat stock trades at the bottom of the page.
Jerome Labat is the Exec. VP & CTO at Cerner.
As the Exec. VP & CTO of Cerner, the total compensation of Mr Labat at Cerner is $852,185. There are 3 executives at Cerner getting paid more, with David Brent Shafer having the highest compensation of $2,321,204.
Mr Labat is 55, he's been the Exec. VP & CTO of Cerner since . There are 3 older and 4 younger executives at Cerner. The oldest executive at Cerner Corp. is Marc G. Naughton, 66, who is the Exec. Advisor.
Over the last 22 years, insiders at Cerner have traded over $915,181,313 worth of Cerner stock and bought 84,702 units worth $5,189,349 . The most active insiders traders include Neal L Patterson, Clifford W Illig, and Jeffrey A Townsend. On average, Cerner executives and independent directors trade stock every 12 days with the average trade being worth of $3,365,003. The most recent stock trade was executed by Michael R. Battaglioli on 4 May 2022, trading 5,288 units of CERN stock currently worth $497,548.
Cerner's health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people.
Cerner executives and other stock owners filed with the SEC include: